公众号 / 文章泌尿生殖技术与安全MRPETCT

前列腺癌诊断与治疗进展

Updates on the diagnosis and treatment of prostate cancer.
PubMed 文献 · Br J Radiol · 2017-05-30

本文为2016年11月英国放射学会在伦敦举办的多学科日活动评论,讨论了前列腺特异性抗原生物标志物、多参数MRI、全身MRI、胆碱PET/CT和镓标记前列腺特异性膜抗原等先进影像技术在前列腺癌检测中的应用,并回顾了PIVOT、ProtecT等干预与观察对比试验及四项比较大分割与标准放疗的随机对照试验,同时涉及近期指南和试验中的热点问题。

要点

  • 多参数MRI、全身MRI、胆碱PET/CT和镓标记PSMA可用于前列腺癌检测。
  • PIVOT和ProtecT试验评估了干预与观察的获益对比。
  • 四项随机对照试验比较了大分割与标准放疗方案。

核心结论

  • 本文评论了前列腺癌诊断与治疗的最新进展,涵盖PSA生物标志物、先进影像技术及多项管理试验结果,并涉及近期指南和试验中的热点问题。

研究设计与样本

  • 本文为英国放射学会于2016年11月在伦敦组织的多学科日活动评论,讨论了前列腺癌诊断与治疗的最新进展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate cancer is the second most prevalent cancer in males worldwide and the commonest cancer in males in the UK. The recent updates on the diagnosis and treatment of prostate cancer were discussed at a multidisciplinary day event organized by the British Institute of Radiology and held in London in November 2016. This day covered the use of the prostate-specific antigen biomarker and of advanced imaging techniques such as multiparametric and whole-body MRI, choline positron emission tomography/CT and gallium-labelled prostate-specific membrane antigen for the detection of prostate cancer. In addition, the results of several trials assessing the management of the disease were discussed, in particular the Prostate Cancer Intervention Versus Observation Trial and Prostate Testing for Cancer and Treatment trials which evaluated the gain of intervention vs observation, and four randomized controlled trials comparing hypofractionated and standard radiotherapy regimen. Further to this event, this commentary highlights the topical issues relating to recently published guidelines and to trials for the management of prostate cancer where these were discussed.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Gasnier A, Parvizi N. Updates on the diagnosis and treatment of prostate cancer. Br J Radiol. 2017. PMID: 28555500. doi:10.1259/bjr.20170180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。